PAROXETINE HYDROCHLORIDE

PAROXETINE HYDROCHLORIDE was reported 41745 times

PAROXETINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SELF MUTILATION 97 0.4199
1 CONGENITAL AORTIC STENOSIS 85 0.4187
2 FALLOT'S TETRALOGY 117 0.3372
3 PERSISTENT FOETAL CIRCULATION 199 0.3262
4 MYOGLOBIN URINE PRESENT 65 0.2642
5 PULMONARY ARTERY STENOSIS CONGENITAL 193 0.2640
6 BICUSPID AORTIC VALVE 155 0.2609
7 PULMONARY VALVE STENOSIS 208 0.2607
8 COARCTATION OF THE AORTA 200 0.2070
9 PULMONARY VALVE STENOSIS CONGENITAL 88 0.2009
10 ACTIVATION SYNDROME 69 0.1994
11 TRANSPOSITION OF THE GREAT VESSELS 143 0.1826
12 PATENT DUCTUS ARTERIOSUS 713 0.1794
13 HYPOPLASTIC LEFT HEART SYNDROME 111 0.1637
14 HEART DISEASE CONGENITAL 555 0.1567
15 ATRIAL SEPTAL DEFECT 1300 0.1551
16 CONGENITAL ANOMALY 1197 0.1545
17 CRANIOSYNOSTOSIS 131 0.1513
18 VENTRICULAR SEPTAL DEFECT 855 0.1492
19 MULTIPLE CONGENITAL ABNORMALITIES 213 0.1479
20 ELECTRIC SHOCK 122 0.1424
21 CONGENITAL HYDROCEPHALUS 71 0.1400
22 TALIPES 399 0.1283
23 COGWHEEL RIGIDITY 120 0.1143
24 DEPERSONALISATION 89 0.1068
25 AGORAPHOBIA 135 0.0986
26 CONGENITAL CARDIOVASCULAR ANOMALY 81 0.0965
27 LIMB MALFORMATION 75 0.0951
28 DRUG EXPOSURE DURING PREGNANCY 3192 0.0937
29 CARDIAC MURMUR 791 0.0913
30 GRANULOMA SKIN 74 0.0901
31 RIGHT VENTRICULAR HYPERTROPHY 80 0.0886
32 CLEFT PALATE 164 0.0848
33 ARNOLD-CHIARI MALFORMATION 75 0.0786
34 AUTISM 79 0.0778
35 SEROTONIN SYNDROME 1467 0.0763
36 DEREALISATION 161 0.0748
37 HOMICIDE 134 0.0727
38 CLEFT LIP AND PALATE 81 0.0725
39 DRUG WITHDRAWAL SYNDROME 6210 0.0707
40 ANTICHOLINERGIC SYNDROME 112 0.0703
41 HALLUCINATIONS, MIXED 285 0.0677
42 FLAT AFFECT 145 0.0626
43 DIABETES MELLITUS NON-INSULIN-DEPENDENT 87 0.0598
44 ANORGASMIA 162 0.0596
45 TEARFULNESS 238 0.0553
46 LIBIDO INCREASED 107 0.0527
47 HOMICIDAL IDEATION 212 0.0522
48 RHONCHI 70 0.0507
49 SPINA BIFIDA 105 0.0504
50 FEELING OF DESPAIR 234 0.0501
51 PULMONARY VALVE INCOMPETENCE 73 0.0499
52 POISONING DELIBERATE 473 0.0498
53 IMPULSIVE BEHAVIOUR 183 0.0487
54 BLOOD PARATHYROID HORMONE DECREASED 72 0.0486
55 PERSONALITY DISORDER 126 0.0481
56 PERFORMANCE STATUS DECREASED 221 0.0473
57 HOSTILITY 120 0.0472
58 CLONUS 128 0.0467
59 HYPERREFLEXIA 162 0.0465
60 HYPOMANIA 168 0.0456
61 SEXUAL DYSFUNCTION 524 0.0446
62 PHYSICAL ASSAULT 92 0.0440
63 OBSESSIVE THOUGHTS 79 0.0438
64 GUN SHOT WOUND 83 0.0437
65 SPEECH DISORDER DEVELOPMENTAL 120 0.0418
66 SOPOR 546 0.0412
67 VENTRICULAR HYPERTROPHY 102 0.0406
68 DILATATION VENTRICULAR 84 0.0399
69 AORTIC VALVE INCOMPETENCE 168 0.0394
70 OBSESSIVE-COMPULSIVE DISORDER 310 0.0386
71 EMOTIONAL POVERTY 67 0.0382
72 BREATH SOUNDS ABNORMAL 184 0.0373
73 TRICUSPID VALVE INCOMPETENCE 296 0.0372
74 HYPERACUSIS 137 0.0368
75 NEUROLEPTIC MALIGNANT SYNDROME 433 0.0365
76 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 72 0.0364
77 YAWNING 97 0.0363
78 EJACULATION FAILURE 72 0.0359
79 DIABETIC NEUROPATHY 177 0.0357
80 NIGHTMARE 1233 0.0356
81 SUICIDAL IDEATION 3259 0.0356
82 SELF INJURIOUS BEHAVIOUR 108 0.0354
83 MANIA 580 0.0352
84 DISSOCIATION 266 0.0347
85 PANIC ATTACK 1244 0.0341
86 PANNICULITIS 82 0.0339
87 LOGORRHOEA 119 0.0337
88 ALCOHOL ABUSE 90 0.0336
89 AGGRESSION 1673 0.0334
90 MYDRIASIS 427 0.0333
91 DEPRESSIVE SYMPTOM 117 0.0332
92 DRUG TOLERANCE DECREASED 92 0.0327
93 HYPOSPADIAS 68 0.0327
94 DYSMORPHISM 77 0.0327
95 FOETAL EXPOSURE DURING PREGNANCY 2650 0.0326
96 MATERNAL DRUGS AFFECTING FOETUS 247 0.0322
97 SELF-INJURIOUS IDEATION 134 0.0319
98 DIABETIC COMA 89 0.0318
99 SUICIDE ATTEMPT 1882 0.0310
100 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 317 0.0308
101 AGITATION 2262 0.0308
102 LOSS OF LIBIDO 277 0.0308
103 ANOREXIA 396 0.0307
104 BRADYPHRENIA 200 0.0306
105 INTENTIONAL SELF-INJURY 615 0.0304
106 HALLUCINATION, AUDITORY 476 0.0299
107 HYPERPARATHYROIDISM SECONDARY 75 0.0299
108 SELF ESTEEM DECREASED 72 0.0297
109 NEPHROGENIC ANAEMIA 137 0.0295
110 SOCIAL AVOIDANT BEHAVIOUR 169 0.0292
111 VISUAL DISTURBANCE 167 0.0291
112 MAJOR DEPRESSION 210 0.0287
113 PANIC DISORDER 111 0.0286
114 BLEPHAROSPASM 180 0.0286
115 DEVELOPMENTAL DELAY 255 0.0282
116 NEONATAL RESPIRATORY DISTRESS SYNDROME 99 0.0280
117 ANGER 946 0.0279
118 ALCOHOLISM 119 0.0278
119 DISTURBANCE IN ATTENTION 1469 0.0272
120 ABNORMAL DREAMS 749 0.0271
121 NEGATIVE THOUGHTS 79 0.0269
122 WITHDRAWAL SYNDROME 1132 0.0269
123 RHEUMATOID NODULE 74 0.0268
124 PARKINSONISM 259 0.0265
125 OBESITY 423 0.0265
126 STOMACH DISCOMFORT 137 0.0265
127 TENSION 161 0.0264
128 AFFECTIVE DISORDER 206 0.0262
129 REBOUND ACID HYPERSECRETION 79 0.0261
130 CLUMSINESS 71 0.0260
131 ELECTRIC SHOCK SENSATION 72 0.0257
132 CRYING 930 0.0256
133 SENSORY DISTURBANCE 410 0.0255
134 BIPOLAR DISORDER 274 0.0252
135 THERMAL BURN 178 0.0251
136 MITRAL VALVE INCOMPETENCE 281 0.0248
137 AORTIC STENOSIS 86 0.0247
138 FAILURE TO THRIVE 128 0.0246
139 ANXIETY DISORDER 82 0.0245
140 CEREBRAL HAEMATOMA 82 0.0244
141 HYPERLIPIDAEMIA 291 0.0243
142 AKATHISIA 332 0.0243
143 CARDIOMEGALY 297 0.0241
144 SUICIDAL BEHAVIOUR 100 0.0240
145 MUSCLE RIGIDITY 286 0.0239
146 MOOD SWINGS 758 0.0238
147 BRADYKINESIA 140 0.0237
148 TACHYPHRENIA 82 0.0237
149 PARANOIA 407 0.0236
150 PSYCHIATRIC SYMPTOM 174 0.0236
151 BRUXISM 127 0.0235
152 IRRITABILITY 1412 0.0235
153 WOUND COMPLICATION 80 0.0233
154 DIFFICULTY IN WALKING 80 0.0232
155 LOSS OF EMPLOYMENT 70 0.0232
156 AFFECT LABILITY 221 0.0229
157 RESPIRATORY ACIDOSIS 90 0.0229
158 THINKING ABNORMAL 425 0.0228
159 SINUS TACHYCARDIA 318 0.0224
160 TYPE 2 DIABETES MELLITUS 750 0.0223
161 DECREASED INTEREST 131 0.0222
162 PANIC REACTION 160 0.0221
163 PERSONALITY CHANGE 203 0.0218
164 HYPERTONIA 124 0.0216
165 POST-TRAUMATIC STRESS DISORDER 143 0.0213
166 COMPLETED SUICIDE 1768 0.0212
167 MYOCLONUS 253 0.0212
168 ALCOHOL USE 78 0.0211
169 APATHY 308 0.0211
170 LEFT VENTRICULAR HYPERTROPHY 90 0.0210
171 NERVOUSNESS 1087 0.0208
172 ELECTROENCEPHALOGRAM ABNORMAL 65 0.0206
173 CEREBRAL ATROPHY 82 0.0206
174 RESTLESSNESS 745 0.0203
175 ALTERED STATE OF CONSCIOUSNESS 430 0.0198
176 PREMATURE LABOUR 111 0.0196
177 HANGOVER 69 0.0196
178 HYPERHIDROSIS 2502 0.0194
179 RHEUMATOID FACTOR POSITIVE 112 0.0194
180 DRUG ABUSE 1614 0.0194
181 BUNDLE BRANCH BLOCK RIGHT 89 0.0194
182 AMYLASE INCREASED 71 0.0192
183 SLEEP DISORDER 1353 0.0192
184 INCOHERENT 124 0.0191
185 TYPE 1 DIABETES MELLITUS 115 0.0191
186 COMMUNICATION DISORDER 73 0.0191
187 DEPRESSION 4332 0.0190
188 RESTLESS LEGS SYNDROME 346 0.0190
189 HYPERTHERMIA 145 0.0190
190 DELUSION 295 0.0190
191 DISORIENTATION 752 0.0190
192 ANXIETY 5396 0.0189
193 TOXIC ENCEPHALOPATHY 96 0.0189
194 HALLUCINATION, VISUAL 399 0.0189
195 ATELECTASIS 182 0.0188
196 EMOTIONAL DISORDER 580 0.0188
197 TREMOR 3085 0.0186
198 POLYDIPSIA 73 0.0184
199 HYPERCHOLESTEROLAEMIA 178 0.0184
200 VERTIGO 1121 0.0184
201 ABNORMAL BEHAVIOUR 728 0.0184
202 HYDROCEPHALUS 100 0.0183
203 HYPONATRAEMIA 1016 0.0180
204 CONFUSIONAL STATE 2909 0.0180
205 SLEEP APNOEA SYNDROME 343 0.0180
206 MUSCLE TWITCHING 411 0.0178
207 BLOOD TRIGLYCERIDES INCREASED 315 0.0178
208 DRUG INTERACTION 2811 0.0177
209 DELIRIUM 613 0.0176
210 FEELING JITTERY 334 0.0175
211 DYSKINESIA 710 0.0175
212 INCONTINENCE 184 0.0174
213 FEELING OF BODY TEMPERATURE CHANGE 102 0.0174
214 SPINAL OSTEOARTHRITIS 152 0.0173
215 PARAESTHESIA 2720 0.0173
216 COMA 802 0.0168
217 EYE MOVEMENT DISORDER 115 0.0168
218 POISONING 211 0.0168
219 EXTRAPYRAMIDAL DISORDER 417 0.0168
220 DRUG USE DISORDER 141 0.0168
221 PSYCHOTIC DISORDER 495 0.0167
222 HYPERVENTILATION 96 0.0165
223 INTERVERTEBRAL DISC DEGENERATION 153 0.0165
224 ERECTILE DYSFUNCTION 423 0.0165
225 RHINITIS ALLERGIC 73 0.0164
226 METABOLIC DISORDER 95 0.0163
227 DROOLING 113 0.0163
228 PAROSMIA 123 0.0163
229 SENSORY LOSS 131 0.0163
230 BUNDLE BRANCH BLOCK LEFT 69 0.0163
231 CYANOSIS 252 0.0160
232 CHOLECYSTITIS CHRONIC 107 0.0160
233 LEFT VENTRICULAR DYSFUNCTION 107 0.0160
234 DYSLIPIDAEMIA 81 0.0159
235 INTENTIONAL OVERDOSE 1021 0.0159
236 SMALL FOR DATES BABY 79 0.0159
237 TINNITUS 731 0.0159
238 PSYCHOMOTOR HYPERACTIVITY 264 0.0159
239 ECONOMIC PROBLEM 241 0.0159
240 FLANK PAIN 149 0.0159
241 COLITIS MICROSCOPIC 75 0.0158
242 RESPIRATORY DEPRESSION 194 0.0158
243 EUPHORIC MOOD 162 0.0158
244 SKIN NECROSIS 82 0.0158
245 TROPONIN INCREASED 120 0.0158
246 SEDATION 412 0.0157
247 DEPRESSED LEVEL OF CONSCIOUSNESS 621 0.0157
248 ACUTE PULMONARY OEDEMA 88 0.0157
249 HEPATIC CYTOLYSIS 199 0.0156
250 ASPHYXIA 127 0.0155
251 TRISMUS 80 0.0155
252 DISABILITY 306 0.0155
253 LETHARGY 889 0.0154
254 FEAR 415 0.0154
255 ENCEPHALOPATHY 375 0.0153
256 PHARMACEUTICAL PRODUCT COMPLAINT 394 0.0152
257 CORONARY ARTERY STENOSIS 76 0.0151
258 AMNESIA 983 0.0151
259 RED BLOOD CELL SEDIMENTATION RATE INCREASED 166 0.0150
260 DIABETES MELLITUS 1136 0.0149
261 GESTATIONAL DIABETES 71 0.0149
262 RHINITIS 120 0.0149
263 SUPRAVENTRICULAR TACHYCARDIA 142 0.0148
264 DRUG ABUSER 91 0.0148
265 FAECAL INCONTINENCE 71 0.0148
266 MOTOR DYSFUNCTION 150 0.0147
267 BLOOD CHOLESTEROL INCREASED 681 0.0146
268 MUSCLE DISORDER 118 0.0146
269 MOOD ALTERED 395 0.0145
270 INSOMNIA 3841 0.0144
271 COORDINATION ABNORMAL 201 0.0144
272 DEPRESSED MOOD 759 0.0143
273 SOMNOLENCE 2887 0.0143
274 MULTIPLE DRUG OVERDOSE 71 0.0143
275 GRAND MAL CONVULSION 132 0.0143
276 CONVULSION 812 0.0142
277 SPINAL COLUMN STENOSIS 67 0.0142
278 WEIGHT INCREASED 3174 0.0142
279 APNOEA 110 0.0141
280 NIGHT SWEATS 455 0.0141
281 MENSTRUAL DISORDER 116 0.0140
282 SUBSTANCE ABUSE 114 0.0140
283 HYPERPROLACTINAEMIA 90 0.0139
284 SCOLIOSIS 86 0.0139
285 ANHEDONIA 364 0.0138
286 MENTAL STATUS CHANGES 381 0.0137
287 CATATONIA 72 0.0137
288 HYPERSOMNIA 393 0.0137
289 GALACTORRHOEA 88 0.0137
290 DIABETES MELLITUS INADEQUATE CONTROL 242 0.0137
291 EXOSTOSIS 124 0.0136
292 INITIAL INSOMNIA 139 0.0135
293 DYSTONIA 262 0.0135
294 MENTAL IMPAIRMENT 327 0.0135
295 ELECTROCARDIOGRAM QT PROLONGED 483 0.0134
296 DYSARTHRIA 504 0.0134
297 BLOOD CREATINE PHOSPHOKINASE INCREASED 385 0.0134
298 SCHIZOPHRENIA 161 0.0132
299 ASPIRATION 145 0.0132
300 FORMICATION 92 0.0132
301 HALLUCINATION 994 0.0132
302 GLUCOSE TOLERANCE IMPAIRED 78 0.0132
303 HIATUS HERNIA 170 0.0131
304 DRUG LEVEL INCREASED 216 0.0130
305 RESPIRATORY DISTRESS 360 0.0130
306 MEMORY IMPAIRMENT 1791 0.0130
307 CARDIAC VALVE DISEASE 74 0.0129
308 JOINT DISLOCATION 136 0.0129
309 DYSPHORIA 65 0.0128
310 HYPERGLYCAEMIA 462 0.0127
311 IMPAIRED DRIVING ABILITY 144 0.0127
312 LACERATION 119 0.0126
313 NYSTAGMUS 67 0.0126
314 MENTAL DISORDER 549 0.0126
315 PHARYNGOLARYNGEAL PAIN 67 0.0126
316 CONCUSSION 97 0.0125
317 HYPOTONIA 125 0.0125
318 MIDDLE INSOMNIA 233 0.0125
319 TOXICITY TO VARIOUS AGENTS 2102 0.0125
320 ORTHOSTATIC HYPOTENSION 217 0.0124
321 BEHAVIOUR DISORDER 67 0.0124
322 RENAL FAILURE CHRONIC 95 0.0123
323 TIC 67 0.0123
324 DRUG SCREEN POSITIVE 97 0.0123
325 ELECTROCARDIOGRAM ABNORMAL 96 0.0122
326 COGNITIVE DISORDER 569 0.0122
327 INCREASED APPETITE 232 0.0121
328 SKIN LACERATION 132 0.0121
329 CARDIO-RESPIRATORY ARREST 507 0.0121
330 IMPAIRED WORK ABILITY 259 0.0121
331 ECCHYMOSIS 83 0.0121
332 POOR QUALITY SLEEP 260 0.0121
333 ARTERIOSCLEROSIS CORONARY ARTERY 80 0.0121
334 HAEMORRHAGIC STROKE 94 0.0120
335 AUTISM SPECTRUM DISORDER 66 0.0120
336 DIZZINESS POSTURAL 116 0.0120
337 HYPERTRIGLYCERIDAEMIA 70 0.0119
338 OBSTRUCTIVE AIRWAYS DISORDER 133 0.0119
339 IRON DEFICIENCY ANAEMIA 110 0.0119
340 RHABDOMYOLYSIS 496 0.0119
341 TORSADE DE POINTES 93 0.0118
342 FEELING DRUNK 88 0.0118
343 MIOSIS 95 0.0118
344 DIVERTICULUM 84 0.0118
345 DECREASED ACTIVITY 127 0.0118
346 PREMATURE BABY 352 0.0117
347 RIB FRACTURE 240 0.0117
348 DENTAL CARIES 128 0.0116
349 URINARY RETENTION 386 0.0116
350 CORONARY ARTERY DISEASE 350 0.0115
351 HYPOAESTHESIA ORAL 174 0.0115
352 SPEECH DISORDER 602 0.0115
353 BLOOD SODIUM DECREASED 215 0.0114
354 ANGINA UNSTABLE 74 0.0114
355 HEPATITIS ACUTE 74 0.0114
356 PNEUMONIA ASPIRATION 284 0.0114
357 BEDRIDDEN 149 0.0113
358 LUNG INFILTRATION 100 0.0113
359 HYPOKINESIA 164 0.0113
360 SOMNAMBULISM 74 0.0113
361 DRUG TOXICITY 153 0.0112
362 HYDRONEPHROSIS 84 0.0112
363 HEPATOCELLULAR INJURY 159 0.0112
364 SYNOVITIS 202 0.0112
365 APHASIA 338 0.0112
366 STAPHYLOCOCCAL INFECTION 369 0.0112
367 BLOOD LACTATE DEHYDROGENASE INCREASED 176 0.0111
368 URINARY INCONTINENCE 329 0.0111
369 HYPERCALCAEMIA 137 0.0111
370 HAEMATOCRIT DECREASED 220 0.0111
371 RENAL CYST 88 0.0111
372 PHOTOPSIA 70 0.0111
373 BRAIN INJURY 111 0.0111
374 ENERGY INCREASED 65 0.0110
375 WOUND 307 0.0110
376 ARTERIOSCLEROSIS 103 0.0109
377 DIZZINESS 5440 0.0109
378 SINUS BRADYCARDIA 105 0.0109
379 ACTIVITIES OF DAILY LIVING IMPAIRED 215 0.0108
380 ANKLE FRACTURE 168 0.0108
381 SUBDURAL HAEMATOMA 155 0.0108
382 TREATMENT NONCOMPLIANCE 592 0.0108
383 TOOTH ABSCESS 110 0.0108
384 HEPATIC STEATOSIS 201 0.0108
385 BACK INJURY 117 0.0107
386 EATING DISORDER 229 0.0107
387 BRADYCARDIA 567 0.0107
388 VITAMIN D DECREASED 91 0.0106
389 BALANCE DISORDER 916 0.0106
390 OSTEOARTHRITIS 449 0.0106
391 DIABETIC KETOACIDOSIS 254 0.0106
392 EPILEPSY 323 0.0106
393 FOOT DEFORMITY 117 0.0105
394 LIVE BIRTH 88 0.0105
395 TACHYPNOEA 142 0.0104
396 OSTEOPENIA 158 0.0104
397 POLYURIA 85 0.0104
398 ATAXIA 123 0.0104
399 PARALYSIS 148 0.0103
400 LIGAMENT SPRAIN 102 0.0103
401 MUSCLE TIGHTNESS 167 0.0103
402 END STAGE RENAL DISEASE 188 0.0103
403 MIGRAINE 981 0.0103
404 PRESCRIBED OVERDOSE 198 0.0102
405 CHRONIC KIDNEY DISEASE 774 0.0102
406 TACHYCARDIA 904 0.0102
407 INTERVERTEBRAL DISC PROTRUSION 222 0.0101
408 PALPITATIONS 1187 0.0101
409 GASTROOESOPHAGEAL REFLUX DISEASE 813 0.0101
410 HAEMORRHOIDS 197 0.0101
411 BLOOD MAGNESIUM DECREASED 87 0.0101
412 HYPOKALAEMIA 465 0.0101
413 PULMONARY FIBROSIS 193 0.0101
414 RENAL TUBULAR NECROSIS 98 0.0100
415 PULMONARY HYPERTENSION 208 0.0100
416 APPETITE DISORDER 66 0.0099
417 TONGUE DISORDER 72 0.0099
418 DECUBITUS ULCER 81 0.0099
419 BONE DISORDER 181 0.0099
420 INCREASED TENDENCY TO BRUISE 91 0.0099
421 TOOTH FRACTURE 109 0.0099
422 FEELING ABNORMAL 2363 0.0099
423 CHOLESTASIS 189 0.0098
424 CHOLELITHIASIS 322 0.0098
425 DEPENDENCE 538 0.0098
426 DRUG ERUPTION 171 0.0096
427 EMPHYSEMA 97 0.0096
428 IRRITABLE BOWEL SYNDROME 206 0.0096
429 ABASIA 237 0.0096
430 PHOTOSENSITIVITY REACTION 158 0.0096
431 PHOTOPHOBIA 179 0.0095
432 SLUGGISHNESS 97 0.0095
433 HEPATIC ENCEPHALOPATHY 88 0.0094
434 ACIDOSIS 72 0.0094
435 NOCTURIA 114 0.0094
436 HYPOTHERMIA 95 0.0094
437 ADVERSE EVENT 864 0.0094
438 HEAD INJURY 296 0.0093
439 PULMONARY CONGESTION 123 0.0093
440 TARDIVE DYSKINESIA 262 0.0093
441 CARDIOMYOPATHY 137 0.0093
442 HEPATOMEGALY 91 0.0093
443 SINUS CONGESTION 125 0.0092
444 PANCREATITIS 489 0.0092
445 GAMMA-GLUTAMYLTRANSFERASE INCREASED 205 0.0092
446 SCRATCH 97 0.0092
447 SPINAL COMPRESSION FRACTURE 76 0.0092
448 SUDDEN DEATH 97 0.0092
449 DRY MOUTH 740 0.0091
450 HYPOXIA 321 0.0091
451 OXYGEN SATURATION DECREASED 511 0.0091
452 PANCREATITIS ACUTE 204 0.0091
453 BURSITIS 110 0.0091
454 LOSS OF CONSCIOUSNESS 1157 0.0090
455 GASTRITIS 237 0.0090
456 ALANINE AMINOTRANSFERASE INCREASED 550 0.0089
457 VENTRICULAR EXTRASYSTOLES 93 0.0089
458 HEART RATE IRREGULAR 202 0.0089
459 ULCER 142 0.0089
460 BODY TEMPERATURE INCREASED 182 0.0089
461 HYPOAESTHESIA 1335 0.0089
462 DRUG WITHDRAWAL SYNDROME NEONATAL 132 0.0089
463 FIBROMYALGIA 216 0.0089
464 NECK PAIN 494 0.0088
465 INJURY 616 0.0088
466 MALNUTRITION 98 0.0088
467 DYSURIA 322 0.0087
468 ASPARTATE AMINOTRANSFERASE INCREASED 464 0.0087
469 DRUG-INDUCED LIVER INJURY 274 0.0087
470 SHOCK HAEMORRHAGIC 71 0.0087
471 SCAR 149 0.0087
472 FALL 2891 0.0087
473 COLD SWEAT 153 0.0087
474 WHITE BLOOD CELL COUNT INCREASED 332 0.0086
475 MOVEMENT DISORDER 277 0.0086
476 ROAD TRAFFIC ACCIDENT 358 0.0085
477 MUSCLE STRAIN 74 0.0085
478 HYPERTENSION 1809 0.0085
479 CARDIAC FAILURE CONGESTIVE 685 0.0085
480 GALLBLADDER DISORDER 152 0.0085
481 CAESAREAN SECTION 99 0.0085
482 SALIVARY HYPERSECRETION 85 0.0085
483 RESPIRATORY ARREST 234 0.0085
484 BASAL CELL CARCINOMA 132 0.0085
485 BLADDER DISORDER 84 0.0085
486 NERVOUS SYSTEM DISORDER 264 0.0084
487 SPUTUM DISCOLOURED 80 0.0084
488 HYPOGLYCAEMIA 409 0.0084
489 GASTROENTERITIS 123 0.0084
490 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 439 0.0084
491 GENERALISED TONIC-CLONIC SEIZURE 139 0.0084
492 HYPERAESTHESIA 69 0.0084
493 RESPIRATORY DISORDER 251 0.0084
494 IMPAIRED HEALING 275 0.0084
495 ACUTE RESPIRATORY FAILURE 161 0.0084
496 HOT FLUSH 630 0.0084
497 THIRST 148 0.0083
498 ASTHENIA 3097 0.0082
499 VENTRICULAR TACHYCARDIA 136 0.0082
500 HEPATITIS 209 0.0082
501 SKIN ULCER 211 0.0082
502 VISION BLURRED 1120 0.0081
503 HAIR DISORDER 67 0.0081
504 QUALITY OF LIFE DECREASED 109 0.0081
505 INFLUENZA LIKE ILLNESS 668 0.0081
506 ILL-DEFINED DISORDER 491 0.0081
507 LIVER FUNCTION TEST ABNORMAL 235 0.0081
508 MUSCULOSKELETAL CHEST PAIN 125 0.0081
509 EAR PAIN 157 0.0081
510 LEUKOCYTOSIS 146 0.0081
511 MICTURITION URGENCY 92 0.0080
512 CHEST PAIN 1488 0.0080
513 RENAL INJURY 238 0.0080
514 DYSSTASIA 233 0.0080
515 MUSCULOSKELETAL STIFFNESS 699 0.0080
516 SUBARACHNOID HAEMORRHAGE 81 0.0079
517 CONTUSION 765 0.0079
518 WOUND INFECTION 87 0.0079
519 BLOOD ALKALINE PHOSPHATASE INCREASED 197 0.0079
520 CARPAL TUNNEL SYNDROME 111 0.0079
521 MYOCARDIAL ISCHAEMIA 90 0.0079
522 PAIN IN JAW 224 0.0079
523 OSTEOPOROSIS 325 0.0079
524 TOOTH DISORDER 175 0.0079
525 UNRESPONSIVE TO STIMULI 203 0.0079
526 RESPIRATORY FAILURE 573 0.0078
527 BLOOD POTASSIUM INCREASED 127 0.0078
528 INTERNATIONAL NORMALISED RATIO INCREASED 221 0.0077
529 ORAL CANDIDIASIS 102 0.0077
530 SECRETION DISCHARGE 97 0.0077
531 OSTEOMYELITIS 140 0.0077
532 UPPER LIMB FRACTURE 154 0.0077
533 BRONCHITIS 572 0.0077
534 SCIATICA 123 0.0077
535 LIMB INJURY 209 0.0077
536 METABOLIC ACIDOSIS 246 0.0077
537 VITAMIN D DEFICIENCY 75 0.0077
538 NAUSEA 6083 0.0077
539 HEAD DISCOMFORT 136 0.0077
540 HYPOTHYROIDISM 245 0.0077
541 DYSPEPSIA 754 0.0077
542 FEELING COLD 213 0.0076
543 BLOOD UREA INCREASED 128 0.0076
544 HEADACHE 4789 0.0076
545 TUBULOINTERSTITIAL NEPHRITIS 143 0.0076
546 NEUTROPHIL COUNT INCREASED 78 0.0076
547 DIPLOPIA 196 0.0075
548 RENAL FAILURE 997 0.0075
549 EAR DISCOMFORT 77 0.0075
550 LIP DRY 68 0.0075
551 PRESCRIBED UNDERDOSE 149 0.0075
552 NERVE INJURY 83 0.0075
553 CLOSTRIDIUM DIFFICILE COLITIS 79 0.0074
554 TOXIC SKIN ERUPTION 75 0.0074
555 DEMENTIA 208 0.0074
556 LUNG DISORDER 364 0.0074
557 DEAFNESS 194 0.0074
558 BLOOD PRESSURE FLUCTUATION 178 0.0074
559 OESOPHAGITIS 81 0.0074
560 FACIAL PAIN 66 0.0074
561 SYNCOPE 739 0.0074
562 BLOOD POTASSIUM DECREASED 221 0.0073
563 MYOCARDITIS 84 0.0073
564 OVARIAN CYST 73 0.0073
565 BRAIN OEDEMA 92 0.0073
566 HYPERTENSIVE CRISIS 81 0.0073
567 ACUTE KIDNEY INJURY 1111 0.0073
568 PHARYNGITIS 90 0.0072
569 HEART RATE INCREASED 718 0.0072
570 ACUTE HEPATIC FAILURE 99 0.0072
571 HYPERKALAEMIA 254 0.0072
572 TOOTHACHE 131 0.0072
573 CHOLECYSTITIS 86 0.0072
574 ARTHROPATHY 400 0.0072
575 CHILLS 843 0.0072
576 PULMONARY OEDEMA 322 0.0072
577 POLLAKIURIA 299 0.0072
578 RECTAL HAEMORRHAGE 307 0.0071
579 C-REACTIVE PROTEIN INCREASED 259 0.0071
580 BLOOD CALCIUM DECREASED 80 0.0071
581 BODY TEMPERATURE DECREASED 70 0.0071
582 PALLOR 193 0.0071
583 EJECTION FRACTION DECREASED 110 0.0071
584 RENAL FAILURE ACUTE 300 0.0071
585 FOLLICULITIS 74 0.0070
586 AGRANULOCYTOSIS 131 0.0070
587 SWOLLEN TONGUE 220 0.0070
588 COAGULOPATHY 117 0.0070
589 OEDEMA PERIPHERAL 855 0.0070
590 VOMITING 3294 0.0070
591 OVERDOSE 1511 0.0070
592 TOOTH INFECTION 92 0.0070
593 INFLUENZA 778 0.0070
594 MUSCLE SPASMS 1278 0.0070
595 FATIGUE 5406 0.0069
596 VENTRICULAR FIBRILLATION 77 0.0069
597 BLOOD PRESSURE SYSTOLIC INCREASED 135 0.0069
598 DECREASED APPETITE 1607 0.0069
599 FEELING HOT 424 0.0069
600 MEDICATION ERROR 384 0.0069
601 TRANSIENT ISCHAEMIC ATTACK 232 0.0069
602 HYPOTENSION 1377 0.0069
603 PARAESTHESIA ORAL 99 0.0069
604 HYPERBILIRUBINAEMIA 71 0.0068
605 PULMONARY MASS 102 0.0068
606 SINUSITIS 701 0.0068
607 WEIGHT DECREASED 1905 0.0068
608 TENDERNESS 71 0.0068
609 CONDITION AGGRAVATED 2064 0.0068
610 GAIT DISTURBANCE 1299 0.0068
611 PULMONARY EMBOLISM 644 0.0068
612 ANGINA PECTORIS 194 0.0068
613 MATERNAL EXPOSURE DURING PREGNANCY 603 0.0068
614 IMPAIRED GASTRIC EMPTYING 92 0.0067
615 VISUAL ACUITY REDUCED 224 0.0067
616 STATUS EPILEPTICUS 76 0.0067
617 ABDOMINAL PAIN 1563 0.0067
618 WEIGHT FLUCTUATION 70 0.0067
619 DEHYDRATION 891 0.0067
620 HEMIPARESIS 113 0.0067
621 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 320 0.0067
622 CONSTIPATION 1450 0.0066
623 ASTHMA 751 0.0066
624 CORONARY ARTERY OCCLUSION 91 0.0066
625 HYPOMAGNESAEMIA 92 0.0066
626 PLATELET COUNT INCREASED 86 0.0066
627 FOOT FRACTURE 125 0.0066
628 ORAL PAIN 147 0.0066
629 BREAST PAIN 70 0.0066
630 BLOOD PRESSURE INCREASED 1001 0.0065
631 DYSPHAGIA 615 0.0065
632 MUSCLE ATROPHY 82 0.0065
633 MUSCULOSKELETAL PAIN 339 0.0065
634 JAUNDICE 174 0.0065
635 ROTATOR CUFF SYNDROME 83 0.0065
636 INTENTIONAL DRUG MISUSE 135 0.0065
637 PNEUMOTHORAX 102 0.0064
638 DYSPNOEA EXERTIONAL 242 0.0064
639 CARDIAC ARREST 530 0.0064
640 PRESYNCOPE 156 0.0064
641 PLEURAL EFFUSION 390 0.0064
642 PERIPHERAL COLDNESS 88 0.0064
643 HAEMATOMA 166 0.0064
644 UPPER GASTROINTESTINAL HAEMORRHAGE 107 0.0064
645 TASTE DISORDER 129 0.0064
646 THERAPEUTIC RESPONSE UNEXPECTED 285 0.0063
647 HAEMATEMESIS 161 0.0063
648 HIP FRACTURE 204 0.0063
649 CARDIOGENIC SHOCK 91 0.0063
650 JOINT STIFFNESS 166 0.0063
651 CYST 78 0.0063
652 HEPATIC ENZYME INCREASED 426 0.0062
653 MYALGIA 1061 0.0062
654 RETCHING 133 0.0062
655 HEART RATE DECREASED 219 0.0062
656 CELLULITIS 314 0.0062
657 MUSCULAR WEAKNESS 708 0.0062
658 RED BLOOD CELL COUNT DECREASED 178 0.0062
659 LYMPHADENOPATHY 220 0.0062
660 PULMONARY ARTERIAL HYPERTENSION 90 0.0062
661 ARRHYTHMIA 294 0.0062
662 WRIST FRACTURE 74 0.0062
663 MOUTH ULCERATION 130 0.0062
664 PERICARDITIS 103 0.0061
665 ARTHRITIS 482 0.0061
666 NASAL CONGESTION 360 0.0061
667 URINARY TRACT INFECTION 1044 0.0061
668 DIARRHOEA 3930 0.0061
669 INFLAMMATION 314 0.0061
670 DEEP VEIN THROMBOSIS 394 0.0061
671 GASTRIC DISORDER 208 0.0061
672 SKIN DISORDER 202 0.0061
673 PELVIC PAIN 110 0.0060
674 BURNING SENSATION 423 0.0060
675 DRUG DEPENDENCE 966 0.0060
676 GASTRIC ULCER 114 0.0060
677 MUSCULOSKELETAL DISCOMFORT 103 0.0060
678 GASTROENTERITIS VIRAL 108 0.0060
679 EMOTIONAL DISTRESS 720 0.0059
680 ADVERSE DRUG REACTION 534 0.0059
681 JOINT INJURY 127 0.0059
682 CYSTITIS 189 0.0059
683 BACK PAIN 1378 0.0059
684 ABDOMINAL PAIN UPPER 1221 0.0059
685 INTERSTITIAL LUNG DISEASE 287 0.0059
686 DIVERTICULITIS 164 0.0059
687 BLOOD IRON DECREASED 70 0.0059
688 DRUG ADMINISTRATION ERROR 181 0.0059
689 BLINDNESS UNILATERAL 83 0.0059
690 TENDONITIS 91 0.0059
691 RENAL DISORDER 273 0.0059
692 SWELLING FACE 381 0.0058
693 EYE PAIN 330 0.0058
694 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 415 0.0058
695 CEREBRAL HAEMORRHAGE 208 0.0058
696 PERICARDIAL EFFUSION 134 0.0058
697 EXPOSURE DURING PREGNANCY 360 0.0058
698 LOCAL SWELLING 101 0.0058
699 ANAEMIA 1103 0.0058
700 MUSCLE SPASTICITY 71 0.0058
701 BLOOD BILIRUBIN INCREASED 156 0.0058
702 ISCHAEMIC STROKE 103 0.0058
703 WHEEZING 342 0.0058
704 ELECTROLYTE IMBALANCE 67 0.0058
705 HEPATIC CIRRHOSIS 108 0.0057
706 JOINT RANGE OF MOTION DECREASED 77 0.0057
707 PRODUCT ADMINISTRATION ERROR 116 0.0057
708 BLOOD CREATININE INCREASED 374 0.0057
709 MULTI-ORGAN FAILURE 99 0.0057
710 BLOOD PRESSURE DECREASED 380 0.0057
711 ILEUS 71 0.0057
712 TOOTH EXTRACTION 71 0.0057
713 RASH PRURITIC 309 0.0057
714 CHOLECYSTECTOMY 65 0.0057
715 SEIZURE 657 0.0057
716 DYSGEUSIA 422 0.0057
717 GLAUCOMA 109 0.0057
718 SINUS DISORDER 112 0.0056
719 THYROID DISORDER 87 0.0056
720 PREGNANCY 113 0.0056
721 NEURALGIA 137 0.0056
722 DRUG INTOLERANCE 544 0.0056
723 UPPER RESPIRATORY TRACT INFECTION 260 0.0056
724 HAIR COLOUR CHANGES 70 0.0056
725 LOWER LIMB FRACTURE 108 0.0056
726 HAIR TEXTURE ABNORMAL 75 0.0056
727 OSTEONECROSIS OF JAW 138 0.0056
728 FLATULENCE 316 0.0056
729 SKIN DISCOLOURATION 256 0.0056
730 OEDEMA 302 0.0056
731 CATARACT 331 0.0056
732 HAEMORRHAGE INTRACRANIAL 83 0.0055
733 CHROMATURIA 125 0.0055
734 CARDIAC DISORDER 518 0.0055
735 STEVENS-JOHNSON SYNDROME 123 0.0055
736 HEPATIC FAILURE 166 0.0055
737 MELAENA 121 0.0055
738 RASH MACULO-PAPULAR 122 0.0055
739 MALAISE 2402 0.0055
740 FEEDING DISORDER 111 0.0055
741 DISSEMINATED INTRAVASCULAR COAGULATION 77 0.0055
742 ORAL DISCOMFORT 76 0.0055
743 ACUTE MYOCARDIAL INFARCTION 161 0.0055
744 HUNGER 76 0.0055
745 EAR INFECTION 145 0.0054
746 THERAPEUTIC RESPONSE DECREASED 330 0.0054
747 FAECES DISCOLOURED 118 0.0054
748 CHEST DISCOMFORT 555 0.0054
749 PRURITUS GENERALISED 117 0.0054
750 SHOCK 124 0.0054
751 DYSPNOEA 3045 0.0054
752 HAEMOGLOBIN DECREASED 551 0.0054
753 ABORTION SPONTANEOUS 214 0.0053
754 THERAPEUTIC PRODUCT EFFECT DECREASED 239 0.0053
755 ABDOMINAL DISTENSION 557 0.0053
756 BLOOD URINE PRESENT 101 0.0053
757 HYPOPHAGIA 136 0.0053
758 VISUAL IMPAIRMENT 657 0.0053
759 FUNGAL INFECTION 175 0.0052
760 PAIN IN EXTREMITY 1544 0.0052
761 NEPHROLITHIASIS 240 0.0052
762 PRODUCT SUBSTITUTION ISSUE 301 0.0052
763 MASS 73 0.0052
764 PYREXIA 1806 0.0052
765 PRODUCTIVE COUGH 249 0.0052
766 ACUTE RESPIRATORY DISTRESS SYNDROME 92 0.0052
767 MUSCULOSKELETAL DISORDER 99 0.0052
768 GASTROINTESTINAL HAEMORRHAGE 434 0.0052
769 LACTIC ACIDOSIS 168 0.0052
770 SEASONAL ALLERGY 73 0.0052
771 CONTRAINDICATED PRODUCT ADMINISTERED 156 0.0051
772 BLOOD COUNT ABNORMAL 78 0.0051
773 SKIN LESION 141 0.0051
774 PAIN 3156 0.0051
775 LIVER DISORDER 226 0.0051
776 DYSPHONIA 298 0.0051
777 INTENTIONAL PRODUCT MISUSE 446 0.0051
778 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 131 0.0051
779 HEPATIC FUNCTION ABNORMAL 190 0.0051
780 SNEEZING 114 0.0051
781 NEUROPATHY PERIPHERAL 483 0.0051
782 CHOKING 99 0.0051
783 PHARYNGEAL OEDEMA 78 0.0051
784 FLUSHING 515 0.0051
785 HAEMATOCHEZIA 279 0.0051
786 GASTROINTESTINAL DISORDER 451 0.0050
787 THERAPY NON-RESPONDER 226 0.0050
788 HAEMOPTYSIS 140 0.0050
789 LIMB DISCOMFORT 155 0.0050
790 ARTHRALGIA 2079 0.0050
791 RHINORRHOEA 323 0.0050
792 DRUG EFFECT DECREASED 268 0.0050
793 GLOSSODYNIA 111 0.0050
794 INFUSION RELATED REACTION 328 0.0049
795 ABDOMINAL DISCOMFORT 830 0.0049
796 HAEMATURIA 169 0.0049
797 PNEUMONIA 1597 0.0049
798 HERNIA 95 0.0049
799 AMENORRHOEA 86 0.0049
800 FACE OEDEMA 82 0.0049
801 FRACTURE 92 0.0049
802 MYOCARDIAL INFARCTION 846 0.0048
803 OROPHARYNGEAL PAIN 448 0.0048
804 BRONCHOSPASM 69 0.0048
805 BLOOD PRESSURE ABNORMAL 96 0.0048
806 TOOTH LOSS 100 0.0048
807 GENERAL PHYSICAL HEALTH DETERIORATION 558 0.0048
808 GAIT INABILITY 161 0.0048
809 TOXIC EPIDERMAL NECROLYSIS 73 0.0048
810 BACK DISORDER 78 0.0048
811 EOSINOPHILIA 84 0.0048
812 ACCIDENTAL OVERDOSE 175 0.0048
813 THROAT TIGHTNESS 129 0.0048
814 ATRIAL FIBRILLATION 463 0.0047
815 METASTASES TO BONE 78 0.0047
816 CEREBROVASCULAR ACCIDENT 802 0.0047
817 DRUG INEFFECTIVE 6228 0.0047
818 RENAL IMPAIRMENT 397 0.0047
819 JOINT SWELLING 570 0.0047
820 STOMATITIS 286 0.0047
821 FEMUR FRACTURE 146 0.0047
822 RASH GENERALISED 122 0.0047
823 HYPERTHYROIDISM 68 0.0047
824 KIDNEY INFECTION 92 0.0047
825 HERPES ZOSTER 269 0.0047
826 GOUT 84 0.0047
827 LACRIMATION INCREASED 141 0.0047
828 BRAIN FOG 73 0.0047
829 THERAPY CESSATION 238 0.0046
830 FREQUENT BOWEL MOVEMENTS 125 0.0046
831 CEREBRAL INFARCTION 113 0.0046
832 MULTIPLE ORGAN DYSFUNCTION SYNDROME 131 0.0046
833 AGEUSIA 115 0.0046
834 DISCOMFORT 281 0.0046
835 LIVER INJURY 113 0.0046
836 LYMPHOCYTE COUNT DECREASED 81 0.0046
837 DERMATITIS 96 0.0046
838 ABDOMINAL PAIN LOWER 115 0.0045
839 WRONG TECHNIQUE IN DRUG USAGE PROCESS 165 0.0045
840 SWELLING 425 0.0045
841 MOBILITY DECREASED 326 0.0045
842 EPISTAXIS 339 0.0045
843 IMPAIRED QUALITY OF LIFE 65 0.0045
844 RASH PAPULAR 101 0.0045
845 SPINAL FRACTURE 90 0.0045
846 PERIPHERAL SWELLING 688 0.0045
847 ORAL HERPES 87 0.0045
848 VIRAL INFECTION 148 0.0044
849 HYPOCALCAEMIA 84 0.0044
850 IMMUNODEFICIENCY 66 0.0044
851 BONE PAIN 259 0.0044
852 EYE DISORDER 145 0.0044
853 ABSCESS 70 0.0044
854 INTESTINAL OBSTRUCTION 165 0.0044
855 SEPSIS 487 0.0044
856 FLUID RETENTION 221 0.0043
857 CARDIOVASCULAR DISORDER 110 0.0043
858 EYE SWELLING 161 0.0043
859 UNEVALUABLE EVENT 327 0.0043
860 SEPTIC SHOCK 187 0.0043
861 CIRCULATORY COLLAPSE 73 0.0043
862 THROMBOCYTOPENIA 479 0.0043
863 MENORRHAGIA 84 0.0043
864 POST PROCEDURAL COMPLICATION 82 0.0043
865 LOWER RESPIRATORY TRACT INFECTION 194 0.0043
866 TREATMENT FAILURE 352 0.0042
867 MULTIPLE SCLEROSIS RELAPSE 289 0.0042
868 GYNAECOMASTIA 130 0.0042
869 PRURITUS 1608 0.0042
870 MULTIPLE FRACTURES 68 0.0041
871 RASH 1777 0.0041
872 COUGH 1138 0.0041
873 INFECTION 587 0.0041
874 RHEUMATOID ARTHRITIS 460 0.0040
875 CONJUNCTIVITIS 75 0.0040
876 CARDIAC FAILURE 324 0.0040
877 BACTERIAL INFECTION 75 0.0040
878 OSTEONECROSIS 132 0.0040
879 ALOPECIA 786 0.0040
880 LEUKOPENIA 199 0.0040
881 PANCYTOPENIA 222 0.0040
882 BLISTER 223 0.0040
883 THROMBOSIS 319 0.0040
884 BLINDNESS 161 0.0039
885 NASOPHARYNGITIS 728 0.0039
886 PLATELET COUNT DECREASED 419 0.0039
887 DRUG DOSE OMISSION 644 0.0039
888 THROAT IRRITATION 174 0.0039
889 SYSTEMIC LUPUS ERYTHEMATOSUS 137 0.0039
890 MULTIPLE SCLEROSIS 184 0.0038
891 ASCITES 113 0.0038
892 ANGIOEDEMA 170 0.0038
893 PROTEINURIA 73 0.0038
894 URTICARIA 642 0.0038
895 COLITIS 145 0.0038
896 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 65 0.0038
897 BONE MARROW FAILURE 77 0.0038
898 HYPOACUSIS 162 0.0038
899 TRANSAMINASES INCREASED 83 0.0037
900 DRY EYE 186 0.0037
901 FULL BLOOD COUNT DECREASED 75 0.0037
902 HYPERSENSITIVITY 686 0.0037
903 PSORIATIC ARTHROPATHY 149 0.0037
904 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 261 0.0037
905 RASH MACULAR 128 0.0037
906 WHITE BLOOD CELL COUNT DECREASED 392 0.0036
907 DISEASE RECURRENCE 172 0.0036
908 KNEE ARTHROPLASTY 74 0.0035
909 PRODUCT USE IN UNAPPROVED INDICATION 860 0.0035
910 ERYTHEMA 713 0.0035
911 RESPIRATORY TRACT INFECTION 90 0.0035
912 EYE PRURITUS 116 0.0034
913 HAEMORRHAGE 360 0.0034
914 LIP SWELLING 114 0.0034
915 ERUCTATION 66 0.0034
916 PRODUCT DISPENSING ERROR 74 0.0034
917 LOCALISED INFECTION 82 0.0034
918 PNEUMONITIS 92 0.0034
919 GLYCOSYLATED HAEMOGLOBIN INCREASED 85 0.0034
920 PRODUCT PRESCRIBING ERROR 80 0.0034
921 VAGINAL HAEMORRHAGE 145 0.0033
922 INTENTIONAL PRODUCT USE ISSUE 291 0.0033
923 NEUTROPENIA 447 0.0033
924 DRUG EFFECT INCOMPLETE 119 0.0033
925 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 179 0.0033
926 PRODUCT QUALITY ISSUE 443 0.0033
927 LABORATORY TEST ABNORMAL 95 0.0032
928 LIVER FUNCTION TEST INCREASED 69 0.0032
929 BLOOD GLUCOSE INCREASED 605 0.0032
930 CLOSTRIDIUM DIFFICILE INFECTION 70 0.0032
931 PRODUCT PRESCRIBING ISSUE 68 0.0031
932 RASH ERYTHEMATOUS 149 0.0031
933 PROCEDURAL PAIN 86 0.0031
934 ILLNESS 318 0.0031
935 SURGERY 175 0.0030
936 BLOOD GLUCOSE DECREASED 143 0.0030
937 BONE DENSITY DECREASED 92 0.0029
938 PSORIASIS 383 0.0029
939 COLITIS ULCERATIVE 131 0.0029
940 BREAST CANCER FEMALE 78 0.0029
941 PRODUCT USE ISSUE 544 0.0029
942 OFF LABEL USE 2534 0.0029
943 PRODUCT DOSE OMISSION 188 0.0029
944 ECZEMA 150 0.0029
945 SKIN EXFOLIATION 239 0.0028
946 EYE IRRITATION 155 0.0027
947 MUCOSAL INFLAMMATION 70 0.0027
948 UNDERDOSE 192 0.0026
949 OCULAR HYPERAEMIA 124 0.0026
950 ANAPHYLACTIC REACTION 142 0.0026
951 ANAPHYLACTIC SHOCK 66 0.0026
952 MENSTRUATION IRREGULAR 68 0.0025
953 NEUTROPHIL COUNT DECREASED 103 0.0025
954 INJECTION SITE MASS 93 0.0025
955 HOSPITALISATION 385 0.0025
956 DISEASE PROGRESSION 289 0.0024
957 ACNE 185 0.0024
958 PAIN OF SKIN 65 0.0024
959 INJECTION SITE REACTION 166 0.0024
960 DRY SKIN 322 0.0024
961 FEBRILE NEUTROPENIA 160 0.0024
962 INCORRECT DRUG ADMINISTRATION DURATION 67 0.0024
963 SKIN BURNING SENSATION 170 0.0024
964 INTENTIONAL DOSE OMISSION 67 0.0023
965 INCORRECT DOSE ADMINISTERED 520 0.0023
966 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 460 0.0023
967 THERAPEUTIC RESPONSE SHORTENED 72 0.0022
968 LUNG NEOPLASM MALIGNANT 88 0.0021
969 INJECTION SITE BRUISING 170 0.0021
970 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 384 0.0021
971 DEATH 1819 0.0021
972 COVID-19 370 0.0021
973 MALIGNANT NEOPLASM PROGRESSION 211 0.0021
974 EXTRA DOSE ADMINISTERED 82 0.0020
975 DEVICE BREAKAGE 82 0.0020
976 PRODUCT DOSE OMISSION ISSUE 579 0.0020
977 INJECTION SITE HAEMORRHAGE 152 0.0019
978 DEVICE DISLOCATION 81 0.0019
979 INJECTION SITE PAIN 568 0.0018
980 INJECTION SITE PRURITUS 124 0.0018
981 PLASMA CELL MYELOMA 70 0.0018
982 BREAST CANCER 165 0.0018
983 THERAPY INTERRUPTED 125 0.0017
984 INJECTION SITE ERYTHEMA 216 0.0017
985 NEOPLASM MALIGNANT 112 0.0017
986 DEVICE MALFUNCTION 110 0.0016
987 DERMATITIS ATOPIC 80 0.0015
988 INJECTION SITE SWELLING 114 0.0015
989 DEVICE ISSUE 133 0.0015
990 ACCIDENTAL EXPOSURE TO PRODUCT 102 0.0010
991 NO ADVERSE EVENT 170 0.0009